Clarius Group LLC Decreases Stock Holdings in Danaher Corporation $DHR

Clarius Group LLC trimmed its holdings in Danaher Corporation (NYSE:DHR) by 19.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,275 shares of the conglomerate’s stock after selling 774 shares during the quarter. Clarius Group LLC’s holdings in Danaher were worth $647,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. AMF Tjanstepension AB lifted its stake in Danaher by 117.0% in the 2nd quarter. AMF Tjanstepension AB now owns 373,173 shares of the conglomerate’s stock worth $73,733,000 after purchasing an additional 201,242 shares in the last quarter. Sava Infond d.o.o. increased its holdings in shares of Danaher by 28.0% during the 2nd quarter. Sava Infond d.o.o. now owns 5,300 shares of the conglomerate’s stock worth $1,047,000 after buying an additional 1,160 shares during the last quarter. 111 Capital increased its holdings in shares of Danaher by 81.3% during the 2nd quarter. 111 Capital now owns 5,908 shares of the conglomerate’s stock worth $1,167,000 after buying an additional 2,649 shares during the last quarter. Ameriflex Group Inc. increased its holdings in shares of Danaher by 95.8% during the 2nd quarter. Ameriflex Group Inc. now owns 374 shares of the conglomerate’s stock worth $75,000 after buying an additional 183 shares during the last quarter. Finally, Franklin Street Advisors Inc. NC increased its holdings in shares of Danaher by 39.4% during the 2nd quarter. Franklin Street Advisors Inc. NC now owns 2,886 shares of the conglomerate’s stock worth $570,000 after buying an additional 815 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target for the company in a report on Friday, July 11th. Weiss Ratings restated a “hold (c-)” rating on shares of Danaher in a report on Saturday, September 27th. UBS Group cut their price target on shares of Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. Finally, Robert W. Baird lifted their target price on shares of Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a report on Friday, July 18th. Seventeen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $245.91.

Danaher Stock Up 2.2%

Danaher stock opened at $215.05 on Monday. The firm has a 50 day moving average price of $200.19 and a 200 day moving average price of $197.24. The company has a market capitalization of $153.98 billion, a PE ratio of 45.75, a price-to-earnings-growth ratio of 3.06 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.41.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company’s quarterly revenue was up 3.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s payout ratio is 27.23%.

Insider Activity at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the business’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 11.20% of the stock is currently owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.